Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/17173900

Download in:

View as

General Info

PMID
17173900